• Je něco špatně v tomto záznamu ?

Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma

T. Fenclova, F. Marecek, I. Hrachovinova

. 2023 ; 34 (6) : 377-384. [pub] 20230719

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016323

OBJECTIVES: Degradation of coagulation proteins in frozen plasma may influence assay results. The aims of this study were to explore the changes in coagulation parameters in patient plasma and internal quality control (IQC) after different freezing and storage conditions during the short-term and long-term periods. METHODS: Platelet poor plasma was prepared from citrated peripheral blood collected from a group of healthy donors. The plasma was pooled, frozen and stored in a variety of freezing and storage conditions. The changes were monitored using routine coagulation assays, as well as factor VIII (FVIII) and protein S (PS) assays. RESULTS: Plasma stored in liquid nitrogen (LN 2 ) or in -80°C showed long-term stable values for routine tests for a period of over 12 months, and 6 months for FVIII. Interestingly, the activated partial thromboplastin time (aPTT) showed a temporary significant prolongation over the first two weeks. Plasma frozen and stored in -40°C is not viable for aPTT and FVIII testing, otherwise it can be used for other parameters for up to 4 months. PS showed a significant increase in all frozen samples. Freezing rate has a significant impact on plasma quality and the final storage temperature influences the long-term stability. CONCLUSION: The optimal storage conditions are ultra-low temperatures (LN 2 or -80°C) and the highest freezing rate possible. However, frozen plasma is not viable for IQC of aPTT during a period of two weeks after freezing. This study is unique in its conception as a practical guide for the handling of frozen plasma samples in modern laboratory settings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016323
003      
CZ-PrNML
005      
20231026110028.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MBC.0000000000001239 $2 doi
035    __
$a (PubMed)37577899
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Fenclova, Tereza $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis $u Charles University, First Faculty of Medicine, Prague, Czech Republic
245    10
$a Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma / $c T. Fenclova, F. Marecek, I. Hrachovinova
520    9_
$a OBJECTIVES: Degradation of coagulation proteins in frozen plasma may influence assay results. The aims of this study were to explore the changes in coagulation parameters in patient plasma and internal quality control (IQC) after different freezing and storage conditions during the short-term and long-term periods. METHODS: Platelet poor plasma was prepared from citrated peripheral blood collected from a group of healthy donors. The plasma was pooled, frozen and stored in a variety of freezing and storage conditions. The changes were monitored using routine coagulation assays, as well as factor VIII (FVIII) and protein S (PS) assays. RESULTS: Plasma stored in liquid nitrogen (LN 2 ) or in -80°C showed long-term stable values for routine tests for a period of over 12 months, and 6 months for FVIII. Interestingly, the activated partial thromboplastin time (aPTT) showed a temporary significant prolongation over the first two weeks. Plasma frozen and stored in -40°C is not viable for aPTT and FVIII testing, otherwise it can be used for other parameters for up to 4 months. PS showed a significant increase in all frozen samples. Freezing rate has a significant impact on plasma quality and the final storage temperature influences the long-term stability. CONCLUSION: The optimal storage conditions are ultra-low temperatures (LN 2 or -80°C) and the highest freezing rate possible. However, frozen plasma is not viable for IQC of aPTT during a period of two weeks after freezing. This study is unique in its conception as a practical guide for the handling of frozen plasma samples in modern laboratory settings.
650    _2
$a lidé $7 D006801
650    _2
$a zmrazování $7 D005615
650    12
$a krevní plazma $7 D010949
650    _2
$a parciální tromboplastinový čas $7 D010314
650    _2
$a hemokoagulace $7 D001777
650    _2
$a vyšetření krevní srážlivosti $7 D001780
650    12
$a hemostatika $7 D006490
655    _2
$a časopisecké články $7 D016428
700    1_
$a Marecek, Frantisek $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis
700    1_
$a Hrachovinova, Ingrid $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis
773    0_
$w MED00009346 $t Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis $x 1473-5733 $g Roč. 34, č. 6 (2023), s. 377-384
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37577899 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110023 $b ABA008
999    __
$a ok $b bmc $g 2000063 $s 1202685
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 34 $c 6 $d 377-384 $e 20230719 $i 1473-5733 $m Blood coagulation & fibrinolysis $n Blood Coagul Fibrinolysis $x MED00009346
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...